Contact
Please use this form to send email to PR contact of this press release:
Advanced Renal Cell Carcinoma Pipeline 2024 | Merck Sharp & Dohme, Chia Tai Tianqing Pharmaceutical, Hoffmann-La Roche
TO:
Yash Bhardwaj
DelveInsight
+91 9650213330